WallStSmart
IMTX

Immatics NV

NASDAQ: IMTX · HEALTHCARE · BIOTECHNOLOGY

$10.99
-1.87% today

Updated 2026-04-30

Market cap
$1.50B
P/E ratio
P/S ratio
31.12x
EPS (TTM)
$-1.89
Dividend yield
52W range
$4 – $12
Volume
0.5M

Immatics NV (IMTX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20182019202020212022202320242025
Revenue$3.77M$18.45M$31.25M$34.76M$172.83M$54.00M$155.84M$48.27M
Revenue growth (YoY)+389.4%+69.4%+11.2%+397.2%-68.8%+188.6%-69.0%
Cost of revenue$33.97M$40.09M$67.08M$87.57M$106.78M$118.66M$148.08M
Gross profit$-30.20M$-21.64M$-35.83M$-52.81M$66.05M$-64.67M$155.84M$48.27M
Gross margin-801.1%-117.3%-114.7%-151.9%38.2%-119.8%100.0%100.0%
R&D$33.97M$40.09M$67.08M$87.57M$106.78M$118.66M$148.08M$169.86M
SG&A$7.67M$11.76M$34.19M$33.81M$36.12M$38.20M$46.45M$51.18M
Operating income$-34.41M$-33.01M$-69.72M$-86.29M$29.95M$-101.72M$-38.62M$-179.38M
Operating margin-912.7%-178.9%-223.1%-248.2%17.3%-188.4%-24.8%-371.6%
EBITDA$-31.73M$-28.47M$-207.43M$-87.30M$50.04M$-88.93M$34.46M$-167.47M
EBITDA margin-841.5%-154.3%-663.7%-251.1%29.0%-164.7%22.1%-347.0%
EBIT$-33.97M$-32.32M$-211.55M$-92.77M$43.20M$-96.16M$22.23M$-179.38M
Interest expense$16000.00$170000.00$289000.00$566000.00$1.04M$831000.00$886000.00$908663.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-31.44M$-31.74M$-229.35M$-95.06M$37.51M$-96.99M$15.22M$-188.69M
Net income growth (YoY)-0.9%-622.6%+58.6%+139.5%-358.6%+115.7%-1339.9%
Profit margin-834.1%-172.0%-733.8%-273.5%21.7%-179.6%9.8%-390.9%